Bumetanide (Burinex) tab 1 mg: Supply issue resolved

PHARMAC the supply issue with bumetanide (Burinex) tab 1 mg has been resolved.

We are advised that the registered brand, Burinex, is available for supply again.

Alternative supplied during stock outage

While Burinex was unavailable, the supplier sourced an alternative brand so patients could continue to access treatment. PHARMAC had already listed the brand in the Pharmaceutical Schedule. It was the same alternative brand supplied in May 2020.

The alternative brand was not registered in New Zealand so had to be supplied under Section 29 of the Medicines Act. 

What section 29 means

Section 29 allows for medicines that are not Medsafe approved to be supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – e.g., doctors. 

We know supplying a medicine under section 29 is not ideal. In this case, however, the alternative would be for patients to have no bumetanide 1 mg tablets. 

We apologise for any inconvenience this causes. 

Read more about section 29 prescribing on the Medsafe website(external link)

Information for your patients about what section 29 means – Health Navigator website(external link)